Parenteral Aztreonam in the Treatment of Haemophilus influenzae Type b Meningitis in Egyptian Children
- 1 January 1988
- journal article
- research article
- Published by Taylor & Francis in Scandinavian Journal of Infectious Diseases
- Vol. 20 (1) , 111-112
- https://doi.org/10.3109/00365548809117227
Abstract
13 children, 8 girls and 5 boys, aged 2–15 months (mean 8.5 months), with Haemophilus influenzae meningitis were treated with aztreonam. Aztreonam was administered intramuscularly in a dose of 50 mg/kg every 8 h. 10 of the infants were in coma and 3 were drowsy when first examined in hospital. All except 2 infants, who were in coma and who died within 24 h of starting therapy, recovered quickly. All patients became fully alert within 4–5 days and afebrile within 5 to 6 days.This publication has 7 references indexed in Scilit:
- Increased Incidence of Childhood Bacterial Meningitis: A 25-Year Study in a Defined Population in SwedenScandinavian Journal of Infectious Diseases, 1987
- Penetration of aztreonam into cerebrospinal fluid of patients with bacterial meningitisAntimicrobial Agents and Chemotherapy, 1986
- Clinical Evaluation of Aztreonam Therapy for Serious Infections Due to Gram-Negative BacteriaClinical Infectious Diseases, 1985
- Treatment of Serious Gram-Negative Infections with AztreonamThe Journal of Infectious Diseases, 1984
- Increasing incidence of ampicillin resistance in Hemophilus influenzaeThe Journal of Pediatrics, 1978